Cross Country Healthcare CCRN Income Statement (2010-2026)

NASDAQ CCRN
$13.25 +0.00 (+0.00%)
At close: Jul 28, 2026 · 4:00 PM EDT
Reported Financials

Cross Country Healthcare Quarterly Income Statement

Periods 64 quarters
Latest Mar 2026

Cross Country Healthcare reported revenue of $241.06M and net income of -$4.39M for the quarter ended Mar 2026, down 17.8% year over year. This income statement covers 64 quarters of results from Jun 2010 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue
331.83M374.90M640.68M788.73M753.56M636.10M628.22M622.71M540.70M442.29M414.04M379.17M339.77M315.12M309.94M293.41M274.07M250.05M236.76M241.06M
Cost of RevenueCost of Rev
259.24M291.11M493.53M613.94M583.16M492.55M489.28M483.28M417.56M344.93M323.55M301.88M268.97M250.96M247.95M234.75M218.07M199.12M188.78M193.47M
Gross Profit
72.59M83.79M147.15M174.79M170.41M143.54M138.94M139.42M123.14M97.36M90.49M77.30M70.81M64.16M61.99M58.66M56.00M50.93M47.98M47.59M
Operating items
Amortization - Intangibles
Depreciation & Amortization - TotalDep. & Amort. (Tot)
Selling, General & AdministrativeSG&A
50.34M52.85M66.84M76.85M86.01M80.71M80.64M84.26M78.94M69.63M67.51M63.25M60.26M54.30M55.57M52.49M50.05M46.89M51.25M45.81M
Restructuring CostsRestructuring
0.80M0.48M-1.11M2.50M0.43M0.90M0.35M0.90M0.90M2.10M1.00M0.28M0.30M0.60M1.50M1.30M0.77M
Other Operating ExpensesOther Opex
264.78M295.61M497.88M620.77M589.83M500.72M496.11M494.22M425.67M352.01M332.20M312.10M296.62M256.97M257.52M241.60M229.28M207.63M255.82M198.63M
Operating ExpensesOpex
315.93M348.46M564.72M698.10M674.72M583.92M576.75M578.91M505.51M421.99M400.61M376.25M358.98M312.27M313.37M294.38M279.93M256.02M308.37M245.21M
Operating IncomeOp. Inc
15.90M26.45M75.96M90.63M78.84M52.17M48.24M43.80M35.19M20.30M13.42M2.92M-19.21M2.85M-3.43M-0.98M-5.86M-5.97M-71.61M-4.16M
EBIT
15.90M26.45M75.96M90.63M78.84M52.17M48.24M43.80M35.19M20.30M13.42M2.92M-19.21M2.85M-3.43M-0.98M-5.86M-5.97M-71.61M-4.16M
Non-operating items
Non Operating Interest Expenses
1.20M2.18M2.82M3.52M3.86M3.50M3.52M3.69M3.15M0.67M0.59M0.46M0.57M0.55M0.61M0.54M0.55M0.56M0.57M0.57M
Interest & Investment IncomeInt & Inv Inc
0.01M0.07M0.17M0.23M1.11M0.54M0.68M0.70M0.86M0.88M0.97M
Other Non Operating IncomeOther Non Op Inc.
0.20M0.38M0.15M0.01M-1.90M0.03M-1.80M0.01M-1.70M-0.14M1.06M-0.02M-0.02M-0.41M-0.06M-0.02M0.03M0.05M0.01M
Net income details
EBT
14.91M24.64M73.30M87.12M74.15M48.70M43.12M40.12M30.31M19.50M12.97M3.69M-19.56M3.39M-3.91M-0.90M-5.73M-5.64M-71.25M-3.73M
Tax ProvisionsTaxes
3.36M1.21M-4.27M25.14M21.26M13.91M6.81M10.68M8.96M6.69M3.93M1.00M-3.51M0.83M-0.16M-0.41M0.93M-0.86M11.68M0.53M
Profit After TaxPAT
11.55M23.43M77.57M61.98M52.89M34.79M38.79M29.44M21.34M12.81M9.04M2.69M-16.05M2.56M-3.75M-0.49M-6.66M-4.77M-82.93M-4.39M
Income from Non-Controlling InterestsInc. Minority
Income from Continuing OperationsIncome (Continuing)
11.55M23.43M77.57M61.98M52.89M34.79M36.31M29.44M21.34M12.81M9.04M2.69M-16.05M2.56M-3.75M-0.49M-6.66M-4.77M-82.93M-4.27M
Income from Discontinued OperationsIncome (Discontinued)
Consolidated Net IncomeConsol Net Inc.
11.55M23.43M77.57M61.98M52.89M34.79M36.31M29.44M21.34M12.81M9.04M2.69M-16.05M2.56M-3.75M-0.49M-6.66M-4.77M-82.93M-4.27M
Income towards Parent CompanyParent Net Inc
11.55M23.43M77.57M61.98M52.89M34.79M36.31M29.44M21.34M12.81M9.04M2.69M-16.05M2.56M-3.75M-0.49M-6.66M-4.77M-82.93M-4.27M
Net Income towards Common StockholdersNet Income
11.55M23.43M77.57M61.98M52.89M34.79M36.31M29.44M21.34M12.81M9.04M2.69M-16.05M2.56M-3.75M-0.49M-6.66M-4.77M-82.93M-4.27M
Additional items
EPS (Basic)
0.320.632.111.671.410.940.980.820.600.370.260.08-0.470.08-0.11-0.02-0.20-0.15-2.56-0.14
EPS (Diluted)
0.310.622.071.631.400.930.970.810.600.360.250.08-0.470.08-0.11-0.02-0.20-0.15-2.56-0.14
Shares Outstanding
36.62M36.96M36.69M37.03M37.47M37.10M37.01M35.86M35.35M34.95M35.16M34.22M33.96M33.02M33.38M32.28M32.49M32.52M32.41M31.47M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
37.20M37.58M37.39M37.97M37.76M37.49M37.54M36.56M35.52M35.15M35.48M34.60M33.96M33.06M33.38M32.28M32.49M32.52M32.41M31.47M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
36.96M36.96M37.02M37.44M38.23M37.30M36.30M35.93M35.80M35.15M34.38M34.77M33.81M32.92M32.28M32.78M32.76M32.76M31.72M32.33M
EBITDA
15.90M26.45M75.96M90.63M78.84M52.17M48.24M43.80M35.19M20.30M13.42M2.92M-19.21M2.85M-3.43M-0.98M-5.86M-5.97M-71.61M-4.16M
Interest ExpensesInt Expense
1.20M2.18M2.82M3.52M3.86M3.50M3.52M3.69M3.15M0.67M0.59M0.46M0.57M0.55M0.61M0.54M0.55M0.56M0.57M0.57M
Tax Rate
22.54%4.90%-5.83%28.85%28.67%28.56%15.79%26.63%29.57%34.30%30.31%27.03%17.95%24.61%4.11%45.49%-16.23%15.31%-16.40%-14.25%